2022
DOI: 10.1016/j.bja.2021.09.018
|View full text |Cite
|
Sign up to set email alerts
|

Conflating effect size and minimal clinically important difference. Comment on Br J Anaesth 2021; 126: 1029–37

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 12 publications
0
7
0
Order By: Relevance
“…In addition, the non-inferiority margin was selected with previous research comparing the use of LIA against placebo and genicular nerves block against LIA. This limit is below the clinician-perceived minimal clinically important difference recently reported by Laigaard et al [10,16,25,26]. Likewise, it has been suggested recently that quality of recovery measurement should be performed routinely [27].…”
Section: Discussionmentioning
confidence: 79%
See 1 more Smart Citation
“…In addition, the non-inferiority margin was selected with previous research comparing the use of LIA against placebo and genicular nerves block against LIA. This limit is below the clinician-perceived minimal clinically important difference recently reported by Laigaard et al [10,16,25,26]. Likewise, it has been suggested recently that quality of recovery measurement should be performed routinely [27].…”
Section: Discussionmentioning
confidence: 79%
“…This limit is below the clinician‐perceived minimal clinically important difference recently reported by Laigaard et al. [10, 16, 25, 26]. Likewise, it has been suggested recently that quality of recovery measurement should be performed routinely [27].…”
Section: Discussionmentioning
confidence: 83%
“…Laigaard et al concluded that median clinician-perceived MCIDs in postoperative pain management were 10 mg iv morphine equivalents or 40% of opioid consumption and 15-18 mm or 30% for pain scores ( 28 ). Different analgesia regimens enable most patients to be at low risk for moderate or severe pain ( 29 ). The use of rescue analgesics for a minor reduction in pain scores and opioid consumption has been dampening, and the patients with higher baseline pain scores may be more responsible for treatment effects ( 29 ).…”
Section: Discussionmentioning
confidence: 99%
“…However, we disagree that the minimal clinically important difference (MCID) should dictate the effect size used in a sample size calculation for a clinical trial. 1 The chosen effect size should be clinically or scientifically meaningful, but it need not be the MCID. 2 In addition, the recommended MCIDs of 10 mg IV morphine reduction for 24 h is for total hip arthroplasty or total knee arthroplasty, 3 not for liver resection.…”
Section: Dear Editormentioning
confidence: 99%